Search results
Results from the WOW.Com Content Network
Antibiotics are usually the first choice when treating community-acquired pneumonia, which may or may not be caused by Legionella. The first-line options when Legionella is the causative agent are macrolides and fluoroquinolones. Azithromycin, a type of macrolide, is the preferred choice. For patients with mild illness, the treatment course ...
The fatality rate of Legionnaires' disease has ranged from 5–30% during various outbreaks and approaches 50% for nosocomial infections, especially when treatment with antibiotics is delayed. [38] Hospital-acquired Legionella pneumonia has a fatality rate of 28%, and the principal source of infection in such cases is the drinking-water ...
Legionella pneumophila, the primary causative agent for Legionnaire's disease, is an aerobic, pleomorphic, flagellated, non-spore-forming, Gram-negative bacterium. [1] [2] L. pneumophila is a intracellular parasite that preferentially infects soil amoebae and freshwater protozoa for replication.
Pontiac fever is known to have a short incubation period of 1 to 3 days. No fatalities have been reported and cases resolve spontaneously without treatment. [8] It is often not reported. [9] Age, gender, and smoking do not seem to be risk factors. Pontiac fever seems to affect young people in the age medians of 29 to 32.
Antibiotics are the treatment of choice for bacterial pneumonia, with ventilation (oxygen supplement) as supportive therapy. The antibiotic choice depends on the nature of the pneumonia, the microorganisms most commonly causing pneumonia in the geographical region, and the immune status and underlying health of the individual.
Outbreak of Legionnaires' disease in Napa County sickens 12, killing 1. Gregory Yee. August 4, 2022 at 2:06 AM. A welcome sign greets visitors along St. Helena Highway in Napa Valley.
What is Legionnaires’ disease? The symptoms of the disease include cough, shortness of breath, fever, muscle aches and headaches, according to the Centers for Disease Control and Prevention .
This is achieved through international surveillance of the disease, as well as developments in diagnosis, management and treatment methods. EWGLI is based at the Health Protection Agency - Centre for Infections, Department of Respiratory Diseases (Legionella Section) in Colindale, north London, England.